Laboratory Corporation of America Holdings - Asset Resilience Ratio
Laboratory Corporation of America Holdings (LH) has an Asset Resilience Ratio of 2.89% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check how strategically is Laboratory Corporation of America Holdin's equity deployed to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2004–2025)
This chart shows how Laboratory Corporation of America Holdings's Asset Resilience Ratio has changed over time. See net asset quality index of Laboratory Corporation of America Holdin to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Laboratory Corporation of America Holdings's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see LH stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $532.30 Million | 2.89% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $532.30 Million | 2.89% |
Asset Resilience Insights
- Limited Liquidity: Laboratory Corporation of America Holdings maintains only 2.89% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Laboratory Corporation of America Holdings Industry Peers by Asset Resilience Ratio
Compare Laboratory Corporation of America Holdings's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Fleury S.A.
SA:FLRY3 |
Diagnostics & Research | 16.06% |
|
Wuhan Thalys Med Tech Co Ltd
SHG:603716 |
Diagnostics & Research | 0.12% |
|
Spectral Med Inc
TO:EDT |
Diagnostics & Research | 11.67% |
|
Bcal Diagnostics Ltd
AU:BDX |
Diagnostics & Research | 0.00% |
|
Genetic Signatures Ltd
AU:GSS |
Diagnostics & Research | 60.91% |
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Australian Clinical Labs Ltd
AU:ACL |
Diagnostics & Research | 4.11% |
|
Monash Ivf Group Ltd
AU:MVF |
Diagnostics & Research | 1.60% |
Annual Asset Resilience Ratio for Laboratory Corporation of America Holdings (2004–2025)
The table below shows the annual Asset Resilience Ratio data for Laboratory Corporation of America Holdings.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 2.89% | $532.30 Million | $18.39 Billion | -5.37pp |
| 2024-12-31 | 8.26% | $1.52 Billion | $18.38 Billion | +5.05pp |
| 2023-12-31 | 3.21% | $536.80 Million | $16.73 Billion | +1.08pp |
| 2022-12-31 | 2.13% | $430.00 Million | $20.16 Billion | -5.14pp |
| 2021-12-31 | 7.28% | $1.48 Billion | $20.39 Billion | +0.33pp |
| 2020-12-31 | 6.94% | $1.39 Billion | $20.07 Billion | +5.02pp |
| 2019-12-31 | 1.92% | $346.60 Million | $18.02 Billion | -0.71pp |
| 2018-12-31 | 2.64% | $426.80 Million | $16.19 Billion | +0.73pp |
| 2017-12-31 | 1.91% | $316.60 Million | $16.57 Billion | -1.13pp |
| 2016-12-31 | 3.04% | $433.60 Million | $14.25 Billion | -- |
| 2015-12-31 | 0.00% | $0.00 | $14.29 Billion | -- |
| 2014-12-31 | 0.00% | $0.00 | $7.30 Billion | -- |
| 2013-12-31 | 0.00% | $0.00 | $6.95 Billion | -- |
| 2012-12-31 | 0.00% | $0.00 | $6.81 Billion | -- |
| 2011-12-31 | 0.00% | $0.00 | $6.17 Billion | -- |
| 2009-12-31 | 0.00% | $0.00 | $4.86 Billion | -- |
| 2008-12-31 | 1.54% | $72.00 Million | $4.67 Billion | -0.97pp |
| 2007-12-31 | 2.52% | $109.90 Million | $4.37 Billion | -0.87pp |
| 2006-12-31 | 3.38% | $135.40 Million | $4.00 Billion | +2.93pp |
| 2005-12-31 | 0.46% | $17.70 Million | $3.88 Billion | -0.10pp |
| 2004-12-31 | 0.56% | $20.00 Million | $3.60 Billion | -- |
About Laboratory Corporation of America Holdings
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcoh… Read more